Clinical Trial Update: Expanded Access Program for RP in Adults

View source ↗

Summary

The document notes that the expanded access program for Ocugen's retinitis pigmentosa treatment in adults is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Ocugen RP product (Expanded Access Program)

Snippet

Sponsor: Ocugen | Conditions: Retinitis Pigmentosa | Status: NO_LONGER_AVAILABLE